In recent months the FDA has been trying to figure out how to get the CBD market under control, with the focus on safety. Patrick McCarthy, CEO of Validcare, a cannabis sector-focused health and wellness research company, said the FDA is not going to move forward on regulating CBD until it has some data on specific research.
